IDYA
Price
$17.08
Change
+$0.90 (+5.56%)
Updated
Apr 17 closing price
Capitalization
1.42B
25 days until earnings call
STOK
Price
$7.69
Change
+$0.13 (+1.72%)
Updated
Apr 17, 04:59 PM (EDT)
Capitalization
415.86M
24 days until earnings call
Ad is loading...

IDYA vs STOK

Header iconIDYA vs STOK Comparison
Open Charts IDYA vs STOKBanner chart's image
IDEAYA Biosciences
Price$17.08
Change+$0.90 (+5.56%)
Volume$1.66M
Capitalization1.42B
Stoke Therapeutics
Price$7.69
Change+$0.13 (+1.72%)
Volume$14.03K
Capitalization415.86M
IDYA vs STOK Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. STOK commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and STOK is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (IDYA: $17.08 vs. STOK: $7.69)
Brand notoriety: IDYA and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 134% vs. STOK: 95%
Market capitalization -- IDYA: $1.42B vs. STOK: $415.86M
IDYA [@Biotechnology] is valued at $1.42B. STOK’s [@Biotechnology] market capitalization is $415.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than STOK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while STOK’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 3 bearish.
  • STOK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both IDYA and STOK are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а +8.31% price change this week, while STOK (@Biotechnology) price change was +17.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

STOK is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.42B) has a higher market cap than STOK($416M). STOK YTD gains are higher at: -31.460 vs. IDYA (-33.541). STOK has higher annual earnings (EBITDA): -115.03M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. STOK (239M). STOK has less debt than IDYA: STOK (2.3M) vs IDYA (19.2M). STOK has higher revenues than IDYA: STOK (16.7M) vs IDYA (7M).
IDYASTOKIDYA / STOK
Capitalization1.42B416M340%
EBITDA-323.14M-115.03M281%
Gain YTD-33.541-31.460107%
P/E RatioN/AN/A-
Revenue7M16.7M42%
Total Cash676M239M283%
Total Debt19.2M2.3M836%
FUNDAMENTALS RATINGS
IDYA vs STOK: Fundamental Ratings
IDYA
STOK
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
36
Fair valued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
4994
PRICE GROWTH RATING
1..100
8983
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STOK's Valuation (36) in the null industry is in the same range as IDYA (61). This means that STOK’s stock grew similarly to IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (65) in the null industry is somewhat better than the same rating for STOK (100). This means that IDYA’s stock grew somewhat faster than STOK’s over the last 12 months.

IDYA's SMR Rating (49) in the null industry is somewhat better than the same rating for STOK (94). This means that IDYA’s stock grew somewhat faster than STOK’s over the last 12 months.

STOK's Price Growth Rating (83) in the null industry is in the same range as IDYA (89). This means that STOK’s stock grew similarly to IDYA’s over the last 12 months.

STOK's P/E Growth Rating (100) in the null industry is in the same range as IDYA (100). This means that STOK’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYASTOK
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDSSX71.33N/A
N/A
Fidelity Stock Selec
AWSCX13.69N/A
N/A
Invesco Global Core Equity C
MAPLX21.78N/A
N/A
Morgan Stanley Inst Advantage L
GTSFX32.75N/A
N/A
Invesco Small Cap Growth R6
NWAHX19.83N/A
N/A
Nationwide Janus Henderson Overseas R6

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+5.56%
GRI - IDYA
54%
Loosely correlated
-1.31%
KRYS - IDYA
53%
Loosely correlated
+2.35%
RCKT - IDYA
53%
Loosely correlated
+2.93%
XENE - IDYA
52%
Loosely correlated
+3.94%
ETNB - IDYA
52%
Loosely correlated
+2.89%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with IDYA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
-2.45%
IDYA - STOK
49%
Loosely correlated
-4.71%
QTTB - STOK
49%
Loosely correlated
-8.19%
RNA - STOK
48%
Loosely correlated
-3.45%
RCKT - STOK
47%
Loosely correlated
-5.82%
DNLI - STOK
45%
Loosely correlated
-4.71%
More